Resverlogix Issues a Management Statement

About this update from Resverlogix Corp.

[{"type":"text","content":"\n\n\n\nTSX Exchange Symbol: RVX\n\n\nCALGARY, Oct. 7 /CNW/ - Resverlogix Corp. ("Resverlogix" or the\n"Company") (TSX:RVX) announced today that in light of the recent significant\nmarket drop of Resverlogix shares management feels it is prudent to restate\nthat the company fundamentals remain the same if not stronger in regards to\nthe Company's science and business developments. There is no reason for the\nprice drop other than the current global conditions. Management will present\nan update as to the current business development discussions at the Annual\nGeneral Meeting on October 28th, at the Telus Convention Centre in Calgary\nAlberta at 2:00pm\n\n\nAbout Resverlogix Corp.\n\n\nResverlogix Corp. is a leading biotechnology company engaged in the\ndevelopment of novel therapies for important global medical markets with\nsignificant unmet needs. The NexVas(TM) program is the Company's primary focus\nwhich is to develop novel small molecules that enhance ApoA-I. These vital\ntherapies address the grievous burden of atherosclerosis and other important\ndiseases such as acute coronary syndrome, diabetes, Alzheimer's disease and\nother vascular disorders. The Company's secondary focus is TGF-Beta\nShield(TM), a program that aims to address burgeoning grievous diseases, such\nas cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange\n(TSX:RVX). For further information please visit www.resverlogix.com.\n\n\nThis news release may contain certain forward-looking statements that\nreflect the current views and/or expectations of Resverlogix Corp. with\nrespect to its performance, business and future events. Such statements are\nsubject to a number of risks, uncertainties and assumptions. Actual results\nand events may vary significantly. The TSX Exchange does not accept\nresponsibility for the adequacy or accuracy of this news release.\n\n\n%SEDAR: 00019253E\n\n\n","length":1972,"tagName":"div"}]

More updates from Resverlogix Corp.